Medicure Inc. (OTCMKTS:MCUJF – Get Rating) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 200 shares, a growth of 100.0% from the August 15th total of 100 shares. Based on an average trading volume of 14,900 shares, the short-interest ratio is presently 0.0 days.
Medicure Price Performance
Shares of OTCMKTS MCUJF remained flat at $0.83 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.47 and a quick ratio of 1.16. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $0.84. The company has a market cap of $8.51 million, a P/E ratio of 13.84 and a beta of 0.88. Medicure has a 1-year low of $0.64 and a 1-year high of $1.10.
Get
Medicure alerts:
About Medicure
(Get Rating)
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 2 Reasons Netflix Might Have Just Bottomed Out
- Has 3M Reached the Point of Being so Bad It's Good?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
Medicure Inc. (OTCMKTS:MCUJF – Get Rating) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 200 shares, a growth of 100.0% from the August 15th total of 100 shares. Based on an average trading volume of 14,900 shares, the short-interest ratio is presently 0.0 days.
8月份，新浪空頭股數實現了顯著增長。截至8月31日，空頭股數共有200股，較8月15日的100股增長了100.0%。以14,900股的平均成交量計算，目前短息比率為0.0天。
Medicure Price Performance
Shares of OTCMKTS MCUJF remained flat at $0.83 during trading hours on Thursday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.47 and a quick ratio of 1.16. The firm has a 50 day moving average of $0.80 and a 200-day moving average of $0.84. The company has a market cap of $8.51 million, a P/E ratio of 13.84 and a beta of 0.88. Medicure has a 1-year low of $0.64 and a 1-year high of $1.10.
在週四的交易時間裏，OTCMKTS MCUJF的股價持平於0.83美元。該公司的債務權益比為0.03，流動比率為1.47，速動比率為1.16。該公司的50日移動均線切入位在0.80美元，200日移動均線切入位在0.84美元。該公司市值為851萬美元，市盈率為13.84倍，貝塔係數為0.88。Medicure的一年低點為0.64美元，一年高位為1.10美元。
Get
Medicure
alerts:
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Pharmure Inc是一家生物製藥公司，從事加拿大和美國心血管市場人類療法的研究、開發和商業化。該公司營銷和分銷阿格列斯特注射劑，這是一種糖蛋白GP IIb/IIIa受體拮抗劑，用於治療急性冠脈綜合徵，包括不穩定心絞痛和非Q波心肌梗死。
See Also
- Get a free copy of the StockNews.com research report on Medicure (MCUJF)
- Why Medical Products Maker Repligen May Be A Potential Buy
- At 10%, Is Arbor Realty Trust Dividend Worth It?
- Investors Should Tune Into RF Industries
- 2 Reasons Netflix Might Have Just Bottomed Out
- Has 3M Reached the Point of Being so Bad It's Good?
- 免費獲取StockNews.com的醫療研究報告(MCUJF)
- 為什麼醫療產品製造商Repligen可能成為潛在收購對象
- 在10%的水平上，Arbor Realty Trust的股息值得嗎？
- 投資者應關注RF Industries
- Netflix可能剛剛觸底的兩個原因
- 3M已經到了壞到好的地步了嗎？
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
接受《醫藥日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Medicure和相關公司的最新新聞和分析師評級的每日簡要摘要。
